Severe asthma: Defining, diagnosing, and treating

Journal of Respiratory Diseases

Volumn 21, Issue 3, 2000, Pages 164-174

  Wenzel, Sally E ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; SALMETEROL; THEOPHYLLINE;

ASTHMA; CHRONIC SINUSITIS; DIFFERENTIAL DIAGNOSIS; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG FUNCTION TEST; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; REVIEW; SPIROMETRY;

EID: 0034100981     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Weiss KB. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Annu Rev Public Health. 1993;14:491-513.
2. Guidelines for the Diagnosis and Management of Asthma: Expert Panel Report II. Bethesda, Md: National Institutes of Health; 1997. Publication 97-4051.
3. Chan MT, Leung DY, Szefler SJ, Spahn JD. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol. 1998;101:594-601.
4. Ulrik CS, Backer V, Dirksen A. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma. 1992;29:29-38.
5. Newman K, Dubester SN. Vocal cord dysfunction: masquerader of asthma. Semin Respir Crit Care Med. 1994;15:161-167.
6. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 1992;90:250-256.
7. Newman KB, Mason UGI, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995;152:1382-1386.
8. Goldman J, Muers M. Vocal cord dysfunction and wheezing. Thorax. 1991;46:401-404.
9. Kivity S, Bibi H, Schwarz Y, et al. Variable vocal cord dysfunction presenting as wheezing and exercise-induced asthma. J Asthma. 1986;23:241-244.
10. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis. 1988;137:1502-1504.
11. Wasserfallen J-B, Schaller M-D, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis. 1990;142: 108-111.
12. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax. 1998;53:315-321.
13. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994;331:700-705.
14. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001-1008.
15. Liu AH, Brugman SM, Schaeffer EB, Irvin CG. Reduced lung elasticity may characterize children with severe asthma. Am Rev Respir Dis. 1990;141:A906.
16. Smith L, McFadden ER Jr. Bronchial hyperreactivity revisited. Ann Allergy Asthma Immunol. 1995;74:454-470.
17. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994;88:373-381.
18. Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med. 1994;330:1329-1334.
19. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet. 1994;344:219-224.
20. Pauwels RA, Lofdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 1997;337:1405-1411.
21. Evans DJ, Taylor DA, Zetterstrom O, et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med. 1997;337:1412-1418.
22. Tamaoki J, Kondo M, Sakai N. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med. 1997;155:1235-1240.
23. Lofdahl C-G, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319:87-90.
24. Erzurum SC, Leff JA, Cochran JE. Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study. Ann Intern Med. 1991;114: 353-360.